0 (0%) | 03-28 14:12 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 1-year : | ||
Resists | First : | Second : | ||
Pivot price | ||||
Supports | First : | Second : | ||
MAs | MA(5) : | MA(20) : | ||
MA(100) : | MA(250) : | |||
MACD | MACD : | Signal : | ||
%K %D | K(14,3) : | D(3) : | ||
RSI | RSI(14): | |||
52-week | High : | Low : |
If tomorrow: | Open lower | Open higher |
High: | - | - |
Low: | - | - |
Close: | - | - |
Thu, 01 Oct 2020
Momenta Pharmaceuticals Announces Completion of Proposed Sale to Johnson & Johnson - GlobeNewswire
Wed, 19 Aug 2020
Momenta Enters Definitive Agreement with Johnson & Johnson - GlobeNewswire
Tue, 28 Jul 2020
Momenta Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Nipocalimab in HDFN - GlobeNewswire
Mon, 15 Jun 2020
Momenta Pharmaceuticals Announces Positive Topline Data from Interim Analysis of Phase 2 Vivacity-MG Study of ... - GlobeNewswire
Wed, 26 Feb 2020
Momenta Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results - GlobeNewswire
Thu, 01 Aug 2019
Momenta Pharmaceuticals Launches Phase 2/3 Trial of M281 for the Treatment of Warm Autoimmune Hemolytic ... - GlobeNewswire
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 0 (M) |
Shares Float | 0 (M) |
Held by Insiders | (%) |
Held by Institutions | (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | |
EPS Est Next Qtrly | |
EPS Est This Year | |
EPS Est Next Year | |
Book Value (p.s.) | |
Profit Margin | % |
Operating Margin | % |
Return on Assets (ttm) | % |
Return on Equity (ttm) | % |
Qtrly Rev. Growth | % |
Gross Profit (p.s.) | |
Sales Per Share | |
EBITDA (p.s.) | |
Qtrly Earnings Growth | % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | |
PEG Ratio | |
Price to Book value | |
Price to Sales | |
Price to Cash Flow |
Dividend | |
Forward Dividend | |
Dividend Yield | 0% |
Dividend Pay Date | |
Ex-Dividend Date |